Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
PBYI
#2831
PUMA BIOTECHNOLOGY INC
5.7
0
-23.28%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-23.28%
Monatliche Änderung
-13.64%
6 month change
+11.76%
Jahresänderung
+86.89%
Vorheriger Schlusskurs
7.4
3
Open
5.7
0
Bid
Ask
Low
5.7
0
High
5.7
0
Volumen
58
Märkte
Aktien
Gesundheitswesen
PBYI
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
40.26 M
41.33 M
46.64 M
48.21 M
49.61 M
50.88 M
—
Valuation ratios
Enterprise value
327.75 M
62.52 M
116.43 M
133.55 M
82.09 M
273.08 M
689.14 M
Price to earnings ratio
—
—
—
10.06
4.92
9.75
24.09
Price to sales ratio
—
—
0.81
0.91
0.65
—
—
Price to cash flow ratio
—
—
11.74
7.97
3.85
7.21
21.86
Price to book ratio
—
—
8.59
4.03
1.63
2.31
3.9
Enterprise value to EBITDA ratio
—
31.37
3.68
4.31
2.83
—
—
Profitability ratios
Return on assets %
0.25
0.13
0
0.09
0.14
0.14
0.15
Return on equity %
10.08
11.9
0
0.4
0.33
0.24
0.27
Return on invested capital %
115.32
4.41
0.4
104.46
76.32
130.27
-35.68
Gross margin %
100
74.84
75.84
73.4
72.06
74.53
300.6
Operating margin %
13.51
0.51
10.4
13.85
13.44
16.33
61.56
EBITDA margin %
—
0.79
13.86
13.15
12.6
15.81
68.6
Net margin %
26.65
11.49
0
9.17
13.15
13.62
51.67
Liquidity ratios
Quick ratio
1.25
1.21
1.67
1.5
1.45
1.93
6.6
Current ratio
1.28
1.28
1.73
1.57
1.54
2
6.99
Inventory turnover
—
12.06
9.47
10.8
8.15
8.17
7.06
Asset turnover
0.94
1.08
1.02
1.04
1.04
1.06
1.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.34
0.43
0.44
0.28
0.1
0
0.11
Long term debt to total equity ratio
14.12
39.69
4.55
1.23
0.24
0
0.21
Per share metrics
Operating cash flow per share
—
—
0.35
0.57
0.79
0.83
0.83
EBIT per share
—
—
0.49
0.41
0.39
0.51
0.51
EBITDA per share
—
—
0.7
0.65
0.59
0.71
0.86
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.04
1.03
1.77
1.81
6.96
Net current asset value per share
—
—
2.99
3.28
3.01
3.21
11.41
Tangible book value per share
—
—
-1.09
-0.16
0.83
1.76
5.29
Working capital per share
—
—
1.26
1.19
1.05
1.61
4.87
Book value per share
—
—
0.48
1.12
1.88
2.57
8.87
Puma Biotechnology Inc
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Nachrichten
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates
Puma Biotech: EPS übertrifft Schätzungen um 0,02 $ - Umsatz besser als erwartet
Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates
Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates
Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com
Puma Biotechnology: SVP Douglas Hunt verkauft Aktien im Wert von 52.695 $
Puma Biotechnology: Finanzvorstand Nougues verkauft Aktien für 64.186 US-Dollar
Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI
Puma biotech CFO Nougues sells $64k in shares
Puma Biotechnologie: CEO verkauft Aktien im Wert von rund 204.000 $